Sugi Predict

Sugi Predict / Compounds / SCHEMBL11084284

SCHEMBL11084284

SCHEMBL11084284

COc1cc2nc(N3CCN(C(=O)Cc4ccccc4)CC3)nc(N)c2cc1OC

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRA1A P35348 8/20 0.77
▸ ADRA1B P35368 8/20 0.77
▸ ADRA2B P18089 3/20 0.68
▸ ADRA2C P18825 3/20 0.68
▸ ADRA2A P08913 2/20 0.68
▸ ADRA1D P25100 2/20 0.68
▸ KCNH2 Q12809 2/20 0.68
▸ KDM4E B2RXH2 2/20 0.68
▸ ALDH1A1 P00352 2/20 0.68
▸ LMNA P02545 2/20 0.68
▸ GLA P06280 2/20 0.68
▸ CYP3A4 P08684 2/20 0.68
▸ GAA P10253 2/20 0.68
▸ MAPT P10636 2/20 0.68
▸ HPGD P15428 2/20 0.68
▸ OPRM1 P35372 2/20 0.68
▸ HSD17B10 Q99714 2/20 0.68
▸ MEN1 O00255 1/20 0.68
▸ NPC1 O15118 1/20 0.68
▸ SLC22A2 O15244 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11079015 0.98 ADRA1A (0.75) ADRA1AADRA1BADRA2BADRA2CADRA2A
SCHEMBL20630865 0.92 ADRA1A (0.67) ADRA1AADRA1BADRA2BADRA2CADRA2A
SCHEMBL20630374 0.91 ADRA1A (0.67) ADRA1AADRA1BADRA2BADRA2CADRA2A
SCHEMBL22206374 0.91 ADRA1A (0.69) ADRA1AADRA1BADRA2BADRA2CADRA2A
SCHEMBL20630373 0.91 ADRA1A (0.68) ADRA1AADRA1BADRA2BADRA2CADRA2A
SCHEMBL11084298 0.90 ADRA1A (0.78) ADRA1AADRA1BADRA2BADRA2CADRA2A
Hydrochloric Acid SCHEMBL11085762 0.89 ADRA1A (0.75) ADRA1AADRA1BADRA2BADRA2CADRA2A
SCHEMBL11082105 0.88 ADRA1A (0.66) ADRA1AADRA1BADRA2BADRA2CADRA2A
Hydrochloric Acid SCHEMBL11078439 0.87 ADRA1A (0.65) ADRA1AADRA1BADRA2BADRA2CADRA2A
SCHEMBL11083148 0.86 ADRA1A (0.84) ADRA1AADRA1BADRA2BADRA2CADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4426382-A HYPOTENSIVE AGENTS SANKYO COMPANY LIMITED (JP) 1984-01-17 — — US claimed
US-20240408092-A1 PEPTIDE AND SMALL MOLECULE AGONISTS OF EPHA AND THEIR USES UNIV CASE WESTERN RESERVE (US) 2024-12-12 — — US disclosed
US-11944624-B2 Peptide and small molecule agonists of EphA and their uses CASE WESTERN RESERVE UNIVERSITY (US) 2024-04-02 — — US disclosed
US-20200222405-A1 PEPTIDE AND SMALL MOLECULE AGONISTS OF EPHA AND THEIR USES CASE WESTERN RESERVE UNIVERSITY 2020-07-16 — — US disclosed
US-20200222405-A1 PEPTIDE AND SMALL MOLECULE AGONISTS OF EPHA AND THEIR USES CASE WESTERN RESERVE UNIVERSITY 2020-07-16 — — US disclosed
US-4426382-A HYPOTENSIVE AGENTS SANKYO COMPANY LIMITED (JP) 1984-01-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200222405-A1 PEPTIDE AND SMALL MOLECULE AGONISTS OF EPHA AND THEIR USES EPHA1, EPHA7, EPHA3 ADRA1A 472/4885ADRA1B 648/4885ADRA2B 690/4885
US-11944624-B2 Peptide and small molecule agonists of EphA and their uses EPHA1, EPHA7, EPHA3 ADRA1A 472/4885ADRA1B 648/4885ADRA2B 690/4885
US-20240408092-A1 PEPTIDE AND SMALL MOLECULE AGONISTS OF EPHA AND THEIR USES EPHA1, EPHA7, EPHA3 ADRA1A 472/4885ADRA1B 648/4885ADRA2B 690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.